Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Egypt / NCT06957197
Starting soon Phase 3

Clinical Comparison of Xenograft With Hydrogel Versus Xenograft Alone in the Socket Preservation After Tooth Extraction: A Randomized Controlled Clinical Trial

NCT06957197 · tracked via the Priya Life Science Egypt tracker
Sponsor
Cairo University
Phase
Phase 3
Started
2025-09-22
Last updated
2025-05-04

Condition(s) studied

Socket Perservation

Investigational drug(s) / intervention(s)

Hydrogel with xenograftXenograft →

Hydrogel with xenograft: vehicle to hold xenograft

Xenograft: to maintain the socket

Study summary

Clinical Comparison of xenograft with hydrogel versus xenograft alone in the socket preservation After tooth extraction: A Randomized controlled Clinical Trial The ideal scaffolds used for alveolar ridge preservation are supposed to show good biocompatibility, mechanical properties, and formability for irregularly shaped bone defects, as well as degradation rates matching bone growth . One of the most used synthetic scaffolds is hydrogel. Hydrogels owning three-dimensional cross-linked network structures have physical and chemical properties like human tissues . They can not only simulate the extracellular matrix (ECM) of bone but also allow the storage, and transport of various growth factors, cytokines, and nutrients due to their high permeability .

Eligibility

Sex
ALL
Min age
16 Years
Max age
60 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Adult, systemically healthy patients with hopeless infected teeth and nonrestorable remaining structure or root. Exclusion Criteria: * Systemic or local disease/ condition that would compromise post-operative healing (e.g. Diabetics, patients who in need for systemic corticosteroids).

Primary outcome measure(s)

  • Quantity of bone (bone height) — 3 mounths
    Method of Measurement ;Radiographically Unit of Measurement ;mm

Trial sites (1)

FacilityCityRegionStatus
Cairo University Cairo Cairo Governorate

More Cairo University trials in Egypt

The Link Between Periodontitis, Smoking and Oral Cancer Starting soon
Treating Intrabony Defect With MINST VS MINST Extended PRF Recruiting
Respiratory Exercises Versus Deep Neck Flexor Training in Chronic Mechanical Neck Pain Recruiting
Integrating Aerobic, Respiratory, and Cognitive Training in Acute Heart Failure Starting soon
Preparation Time Of Bioflx Crowns Compared To Zirconia Crowns On Primary Molars Starting soon

Other trials for the same condition

Socket Preservation Using Biodentin Versus Xeno Graft for Single Rooted Teeth Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06957197 on ClinicalTrials.gov ↗ ← All trials in Egypt